drugset / Trial / NCT01896557
Ranitidin Versus Omeprazole in Patients Taking Clopidogrel
Phase 4
Completed
92 enrolled
University of Sao Paulo General Hospital
InCor Heart Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Previous reports have shown a possible drug interaction between clopidogrel and proton pump inhibitors (PPI´s), which could result in increased number of adverse cardiovascular events among patients on dual antiplatelet therapy(DAPT). Because of this, ranitidin has been proposed as an alternative drug to PPI´s for prophylaxis of gastrointestinal bleeding in patients who need DAPT. The study´s aim is to test the hypothesis that ranitidin doesn´t have any influence on clopidogrel pharmacodynamic.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
| Subject | Ranitidine | Unknown | 150 mg | — |